Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Reductive activation of potential antitumor mitosene compounds

M Maliepaard1, N J de Mol, L H Janssen

  • 1Department of Pharmaceutical Chemistry, Utrecht University, The Netherlands.

Journal of Medicinal Chemistry
|July 23, 1993
PubMed
Summary

Reductive activation of mitosene compounds causes loss of leaving groups, with reactivity influenced by pH and substituent groups. Bifunctional mitosenes efficiently form DNA interstrand cross-links, comparable to mitomycin C.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dose selection and tolerability of anticancer agents evaluated by the European Medicines Agency in the period 2015-2020.

ESMO open·2021
Same author

Multi-podant diglycolamides and room temperature ionic liquid impregnated resins: An excellent combination for extraction chromatography of actinides.

Journal of chromatography. A·2016
Same author

Pharmacogenomic information in drug labels: European Medicines Agency perspective.

The pharmacogenomics journal·2015
Same author

Evaluation of several multiple diglycolamide-functionalized calix[4]arene ligands for the isolation of carrier free 90Y from 90Sr.

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine·2014
Same author

Temperature-induced alterations of in vivo chlorophyll a fluorescence induction in cucumber as affected by DCMU.

Photosynthesis research·2014
Same author

Modeling and simulation in clinical pharmacology and dose finding.

CPT: pharmacometrics & systems pharmacology·2013

Area of Science:

  • Medicinal Chemistry
  • Organic Chemistry
  • Molecular Biology

Background:

  • Mitosene compounds are a class of molecules with potential therapeutic applications.
  • Understanding their activation mechanisms is crucial for drug development.
  • Previous studies on mitomycin C provide a basis for comparison.

Purpose of the Study:

  • To investigate the reductive activation of mitosene compounds.
  • To compare the reactivity of different mitosene derivatives.
  • To assess the DNA cross-linking potential of activated mitosenes.

Main Methods:

  • Cyclic voltammetry
  • High-performance liquid chromatography (HPLC) analysis
  • Electrochemical and dithionite reduction

Related Experiment Videos

  • DNA interaction studies

    • Main Results:

    • Reductive activation leads to the loss of leaving groups at C-1 and C-10, accelerated at lower pH.
    • The C-10 site is more reactive in diacetoxymitosenes, unlike mitomycin C's C-1 site.
    • Acid degradation also causes leaving group loss, with differing site selectivity compared to reduction.
    • Bifunctional mitosenes effectively form DNA interstrand cross-links upon reductive activation.

    Conclusions:

    • The reductive activation pathway of mitosenes is pH-dependent and influenced by leaving groups.
    • Diacetoxymitosenes exhibit distinct reactivity patterns compared to mitomycin C.
    • Activated bifunctional mitosenes are potent agents for DNA cross-linking, with efficacy comparable to mitomycin C.